Harvard Medical School Breast Pathology Selective Pathology

Topics

• Breast Cancer Treatment Studies 185
• Breast Lesions and Carcinomas 105
• HER2/EGFR in Cancer Research 32
• AI in cancer detection 17
• Cancer and Skin Lesions 15
• Cancer Cells and Metastasis 15
• BRCA gene mutations in cancer 14
• Cancer Risks and Factors 13
• Breast Implant and Reconstruction 10
• Cancer Genomics and Diagnostics 9
• Cancer Immunotherapy and Biomarkers 9
• Coronary Interventions and Diagnostics 8

Most cited

1. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.

   Annals of oncology : official journal of the European Society for Medical Oncology · 2023 · 290 citations · Stuart Schnitt

2. Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.

   JAMA · 2025 · 74 citations · Stuart Schnitt

3. FATTY ACID SYNTHESIS IS REQUIRED FOR BREAST CANCER BRAIN METASTASIS.

   Nature cancer · 2021 · 293 citations · Elena Brachtel

4. Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer.

   JAMA oncology · 2022 · 210 citations · Stuart Schnitt

5. International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-Low and Ultralow Categories.

   Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2026 · 13 citations · Stuart Schnitt

6. Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies.

   NPJ breast cancer · 2022 · 85 citations · Stuart Schnitt